Pier Capital’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Pier Capital’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-182,209	Closed	-$2.73M	–	138
2023 Q3	$2.73M	Sell	182,209 -45,450	-20%	-$946K	0.44%	90
2023 Q2	$7.4M	Buy	227,659 +68,301	+43%	+$2.49M	1.06%	47
2023 Q1	$6.24M	Buy	159,358 +5,181	+3%	+$253K	0.95%	57
2022 Q4	$8.15M	Buy	+154,177	New	+$7.51M	1.33%	26

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Pier Capital's SILK Position: Q4 2023 in Review

Pier Capital sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 182,209 shares — an estimated $2.73M sold.

Pier Capital first reported a position in SILK in Q4 2022 and held it in 4 quarters. The position peaked at $8.15M in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

Pier Capital reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Pier Capital sold 182,209 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $2.73M.
Pier Capital first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Pier Capital's Silk Road Medical, Inc. Common Stock position peaked at $8.15M in Q4 2022.
133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Pier Capital's 13F filing for Q4 2023, filed 15 Feb 2024.